UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 2, 2007
Natures Sunshine Products, Inc.
(Exact Name of Registrant as Specified in its Charter)
Utah |
|
0-8707 |
|
87-0327982 |
||
(State or other jurisdiction of |
|
(Commission |
|
(IRS Employer |
||
incorporation or organization) |
|
File Number) |
|
Identification No.) |
||
|
|
|
|
|
||
75 East 1700 South |
|
|
||||
Provo, Utah |
|
84606 |
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||||
|
||||||
Registrants Telephone Number, Including Area Code: |
||||||
(801) 342-4300 |
||||||
|
||||||
N/A |
||||||
(Former name, former address, and formal fiscal year, if changed since last report) |
||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
Item 4.01 Changes in Registrants Certifying Accountant
On February 2, 2007, the Audit Committee of the Board of Directors of Natures Sunshine Products, Inc. (the Company) engaged Deloitte & Touche LLP (Deloitte) to serve as the Companys independent registered public accounting firm. On February 6, 2007, the Company issued a press release announcing its engagement of Deloitte, a copy of which is attached hereto as Exhibit 99.1.
During the two-year period ended December 31, 2006, and through February 2, 2007, neither the Company, nor anyone on its behalf, consulted with Deloitte with respect to either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Companys consolidated financial statements, and no written report or oral advice was provided by Deloitte to the Company that Deloitte concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing, or financial reporting issue or (ii) any matter that was the subject of either a disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K or a reportable event as described in Item 304(a)(1)(v) of Regulation S-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description |
|
|
|
99.1 |
|
Press release dated February 6, 2007. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Natures Sunshine Products, Inc. |
||
|
|
|
|
|
|
|
|
Dated: February 8, 2007 |
|
By |
/s/ Stephen M. Bunker |
|
|
|
Chief Financial Officer |
3
EXHIBIT INDEX
Exhibit Number |
|
Exhibit |
|
|
|
99.1 |
|
Press release dated February 6, 2007. |
4